首页> 外文期刊>Journal of Translational Medicine >Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas
【24h】

Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas

机译:癌症基因组图谱和癌细胞系百科全书大规模基因组数据库的综合分析:MUC4 / MUC16 / MUC20签名与人类癌症的低生存率相关

获取原文
           

摘要

MUC4 is a membrane-bound mucin that promotes carcinogenetic progression and is often proposed as a promising biomarker for various carcinomas. In this manuscript, we analyzed large scale genomic datasets in order to evaluate MUC4 expression, identify genes that are correlated with MUC4 and propose new signatures as a prognostic marker of epithelial cancers. Using cBioportal or SurvExpress tools, we studied MUC4 expression in large-scale genomic public datasets of human cancer (the cancer genome atlas, TCGA) and cancer cell line encyclopedia?(CCLE). We identified 187 co-expressed genes for which the expression is correlated with MUC4 expression. Gene ontology analysis showed they are notably involved in cell adhesion, cell–cell junctions, glycosylation and cell signaling. In addition, we showed that MUC4 expression is correlated with MUC16 and MUC20, two other membrane-bound mucins. We showed that MUC4 expression is associated with a poorer overall survival in TCGA cancers with different localizations including pancreatic cancer, bladder cancer, colon cancer, lung adenocarcinoma, lung squamous adenocarcinoma, skin cancer and stomach cancer. We showed that the combination of MUC4, MUC16 and MUC20 signature is associated with statistically significant reduced overall survival and increased hazard ratio in pancreatic, colon and stomach cancer. Altogether, this study provides the link between (i) MUC4 expression and clinical outcome in cancer and (ii) MUC4 expression and correlated genes involved in cell adhesion, cell–cell junctions, glycosylation and cell signaling. We propose the MUC4/MUC16/MUC20high signature as a marker of poor prognostic for pancreatic, colon and stomach cancers.
机译:MUC4是一种膜结合型粘蛋白,可促进致癌性进展,通常被提议作为各种癌症的有前途的生物标志物。在此手稿中,我们分析了大规模基因组数据集,以评估MUC4的表达,鉴定与MUC4相关的基因并提出新的特征作为上皮癌的预后标志物。使用cBioportal或SurvExpress工具,我们研究了人类癌症的大规模基因组公共数据集(癌症基因组图谱,TCGA)和癌细胞系百科全书(CCLE)中的MUC4表达。我们确定了187共表达的基因,其表达与MUC4表达相关。基因本体分析表明它们特别参与细胞粘附,细胞间连接,糖基化和细胞信号传导。另外,我们显示MUC4表达与另外两个膜结合粘蛋白MUC16和MUC20相关。我们显示,MUC4表达与TCGA癌症的总体生存状况较差,TCGA癌症的定位不同,包括胰腺癌,膀胱癌,结肠癌,肺腺癌,肺鳞状腺癌,皮肤癌和胃癌。我们显示,MUC4,MUC16和MUC20签名的组合与胰腺癌,结肠癌和胃癌的统计学显着降低的总生存期和增加的危险比相关。总而言之,这项研究提供了(i)MUC4表达与癌症的临床结果之间的联系,以及(ii)MUC4表达与参与细胞粘附,细胞间连接,糖基化和细胞信号转导的相关基因之间的联系。我们建议使用MUC4 / MUC16 / MUC20high标记物作为胰腺癌,结肠癌和胃癌预后不良的标志。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号